A5079113266- Hematopoietic Stem Cell Transplantation
- Childhood Cancer Survivors' Quality of Life
- Acute Kidney Injury Research
- Blood disorders and treatments
- Acute Lymphoblastic Leukemia research
- Platelet Disorders and Treatments
- Eosinophilic Disorders and Syndromes
- Respiratory Support and Mechanisms
- Renal Transplantation Outcomes and Treatments
- Lysosomal Storage Disorders Research
- Immunodeficiency and Autoimmune Disorders
- Autoimmune Bullous Skin Diseases
- Trypanosoma species research and implications
- Cytokine Signaling Pathways and Interactions
- Parasitic Diseases Research and Treatment
- Neuroblastoma Research and Treatments
- Chronic Kidney Disease and Diabetes
- Pleural and Pulmonary Diseases
- Sepsis Diagnosis and Treatment
- Bone Metabolism and Diseases
Wroclaw Medical University
2020-2024
Background: Although acute kidney injury (AKI) is a common complication in patients undergoing hematopoietic stem cell transplantation (HSCT), its prophylaxis remains clinical challenge. Attempts at prevention or early diagnosis focus on various methods for the identification of factors influencing incidence AKI. Our aim was to test artificial intelligence (AI) potential construction model defining parameters predicting AKI development. Methods: The analysis covered data children followed up...
The markers of renal damage defining subclinical AKI are not widely used in children undergoing allogeneic hematopoietic stem cell transplantation (alloHSCT). aim the study was to evaluate serum and urinary clusterin as indices kidney injury after alloHSCT relation (kidney molecule (KIM)-1) functional (cystatin C) markers.Serum clusterin, KIM-1 cystatin C concentrations were assessed by ELISA 27 before alloHSCT, 24 h, 1, 2, 3 4 weeks controls.All parameters significantly higher HSCT patients...
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a lifesaving procedure in malignant and nonmalignant diseases. However, it associated with considerable risk of graft-versus-host disease (GvHD). Steroids are first-line therapy for acute GvHD (aGvHD), but there no standard treatment steroid-resistant (SR) gastrointestinal (GI) aGvHD, which has poor prognosis. The anti-integrin antibody, vedolizumab, could help controlling SR GI aGvHD symptoms by blocking lymphocyte...
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a treatment method for wide range of malignant and non-malignant diseases. Infants constitute distinct patient group, especially due to their organ immaturity differences in drug metabolism. The present paper aims analyse the short- long-term outcomes after allo-HSCT infants. In study period, 67 patients under 12 months age underwent allo-HSCT. This retrospective analysis medical records, form electronic documentation....
ENWEndNote BIBJabRef, Mendeley RISPapers, Reference Manager, RefWorks, Zotero AMA MiÅkiewicz-MigoÅ I, MiÅkiewicz-Bujna J, Mielcarek-Siedziuk M, FrÄ czkiewicz GorczyÅska E, KaÅwak K. First hematopoietic stem cell transplantation in a child with late infantile Krabbe disease Poland. Pediatria Polska - Polish Journal of Paediatrics. 2021;96(1):68-70. doi:10.5114/polp.2021.104831. APA MiÅkiewicz-MigoÅ, I., MiÅkiewicz-Bujna, J., Mielcarek-Siedziuk, M., czkiewicz, GorczyÅska, E., &...